Decision Diagnostics Corp.
Decision Diagnostics Corp. (DECN) Revenue
Annual & quarterly revenue history · segment & region breakdown
DECN · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDecision Diagnostics Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Medical - PharmaceuticalsCompare DECN revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Decision Diagnostics Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Decision Diagnostics Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Decision Diagnostics Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DECN revenue · 4 questionsDECN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Decision Diagnostics Corp. SEC filings · GAAP · Decision Diagnostics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026